Bibliographic record
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a…
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM. The Lancet 2023
§1Bibliographic record
§1.1Record
- Authors
- Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM
- Title
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
- Source
- The Lancet
- Year
- 2023
- Volume, issue, pages
- 402(10402):613–626
- Digital object identifier
- 10.1016/S0140-6736(23)01200-X
- PubMed identifier
- 37385275
- Record type
- Journal article
- Institute identifier
- CEI-BR-032
§1.2Institute documents citing this record
Table 1. Documents in the Institute set that cite this record.
§1.3Subject tags
tirzepatide obesity t2dm SURMOUNT
Compound Evidence Institute · CEI-BR-032 · https://compoundevidence.com/bibliography/garvey2023/ · retrieved 30 July 2026